ÂÜÀòÂÒÂ×

Yitai Tang is a seasoned investment professional and researcher with extensive experience in the biotech field. Currently serving as a Senior Investment Officer at Altamont Pharmaceutical Holdings since 2021, Yitai Tang specializes in developing biotech investment theses and conducting regular portfolio reviews. Previously, Yitai Tang held the position of Senior Analyst at the same firm from 2018 to 2020, also focusing on investment strategies. A robust research background includes positions as a Research Scientist at Stanford University and HHMI, where Yitai Tang identified key factors in epileptic seizures, and as a Postdoctoral Scientist at Stanford University, developing assays for huntingtin aggregation and microRNA activities. Yitai Tang began academic pursuits at Rice University, culminating in a Ph.D. in Biochemistry and Cell Biology in 2007, and has furthered education at esteemed institutions such as Stanford University and UCSF-Stanford CERSI.